The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy (Q83054376)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 April 2006
edit
Language Label Description Also known as
English
The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy
scientific article published on 01 April 2006

    Statements

    The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit